QCLN has clawed back some ground this week, but the short-interest rebuild that began in late June keeps accelerating — and that tension is the most interesting thing in the data right now.
The price picture has shifted since last week's note, which captured QCLN at its low near $55.13. The ETF closed Tuesday at $54.90, essentially flat on the week (down just 0.4%) after a solid 2.5% bounce on Monday. That's a meaningful change in character from the 10% weekly collapse reported July 8. The one-month loss remains heavy at around 11%, but the selling momentum has clearly stalled. The fund is no longer in free fall.
Short interest tells a more complicated story, though. Bearish positioning has more than doubled over the past month — shares short are up 128% from early June levels and up 66% week-on-week — even as the absolute level remains modest at 1.8% of the free float. The bulk of that build happened in a single step: short shares jumped from roughly 124,000 on July 9 to 213,000 on July 10, almost overnight. That kind of discrete jump in an ETF wrapper often reflects a specific institutional hedging decision rather than broad retail-driven shorting. At 1.8% of float, this isn't a high-conviction short thesis in aggregate, but the velocity of the build is worth tracking.
The borrow market has moved in the opposite direction from last week's note, and the change is substantial. Cost to borrow has eased to 4.37% from a peak near 6.15% on July 7 — a 29% decline over the week — unwinding much of the spike that accompanied the price sell-off. Availability has loosened considerably too, now running at 338%, up from around 196% a week ago and well above the 52-week trough of 27%. That means roughly three-and-a-half shares are available to borrow for every share already borrowed — a comfortable, normal lending environment. The borrow tightness that briefly emerged during the July 7 sell-off has dissipated. Taken together, borrow conditions no longer support a squeeze narrative; the lending pool has plenty of room.
Options positioning adds little drama. The put/call ratio sits at 0.16, fractionally below its 20-day average of 0.165 and barely half a standard deviation from the mean. There's no sign of defensive hedging activity, no rush for downside protection. The 52-week range on the PCR runs from 0.042 to 0.375, and the current reading is squarely unremarkable — options traders are expressing no particular view on direction.
The ORTEX short score has drifted lower this week to 43.5, down from a recent range of 46–47, suggesting the composite short-pressure signal is easing even as raw short interest climbs. That divergence — more shares short but a lower short score — likely reflects the loosening availability and falling borrow cost offsetting the SI build. Institutional ownership data (last reported March 31) shows Morgan Stanley as the largest disclosed holder with around 414,000 shares, though they trimmed by 87,000 shares in Q1. First Trust Advisors, the fund's own advisor, was the only notable buyer in the most recent period, adding roughly 20,000 shares as of June 30.
What to watch next: whether the short interest build — now at its highest level in 30 days — continues to grow or plateaus here, and whether the borrow market re-tightens if clean energy sentiment deteriorates again on any policy or macro newsflow.
See the live data behind this article on ORTEX.
Open QCLN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
